Submitted by Anonymous (not verified) on 9 October 2026 - 14:18
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 7, Status: Authorised